A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)
A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)
The purpose of this study is to evaluate vaccine immunogenicity and how well the body
 tolerates V504 when given with Gardasil.
Inclusion Criteria:

 -  Females between 16- to 26-years-old

 -  Has never had Pap testing or has only had normal Pap test results.

 -  Lifetime history of 0 to 4 sexual partners

 Exclusion Criteria:

 -  History of an abnormal cervical biopsy result

 -  History of a positive test for HPV; History of external genital/vaginal warts

 -  Currently a user of illegal drugs or an alcohol abuser

 -  History of severe allergic reaction that required medical attention

 -  Are pregnant

 -  Received a marketed HPV vaccine

 -  Currently enrolled in a clinical trial

 -  Currently has or has a history of certain medical conditions or is currently taking or
 has taken certain medications (details will be discussed at the time of consent)